Adicet Bio, Inc.
ACET
$6.47
-$0.26-3.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.63% | 13.97% | -10.64% | 1.79% | 5.75% |
| Total Depreciation and Amortization | -6.36% | -4.95% | -1.49% | 3.51% | 1.95% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -- | -- |
| Total Other Non-Cash Items | 118.12% | -12.71% | 1.92% | -12.22% | -56.04% |
| Change in Net Operating Assets | 461.70% | 710.34% | 103.42% | -722.82% | 50.95% |
| Cash from Operations | 6.27% | 16.24% | -4.87% | -5.38% | -9.52% |
| Capital Expenditure | 104.78% | -344.68% | 96.85% | -747.73% | 56.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -361.34% | -48.35% | 2,510.52% | 93.76% | 77.18% |
| Cash from Investing | -364.52% | -48.91% | 1,251.80% | 87.07% | 77.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50,254.67% | -156.18% | 356.73% | -175.91% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 274.13% | -185.33% | 123.22% | 38.46% | 61.14% |